Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 May 24;16(6):181. doi: 10.3390/md16060181

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effect of COS on the activities of SOD, GSH-Px, and CAT, as well as MDA levels of mice liver (A) and kidney (B) caused by d-gal. Data represent means ± SD (n = 8). ^# p < 0.05 compared with the normal group; * p < 0.05 compared with the model group. Normal: normal control group; Model: d-gal-treated group; VE: d-gal plus VE treatment group; COS-L: d-gal plus COS (300 mg/kg/day) treatment group; COS-M: d-gal plus COS (600 mg/kg) treatment group; COS-H: d-gal plus COS (1200 mg/kg) treatment group.

Effect of COS on the activities of SOD, GSH-Px, and CAT, as well as MDA levels of mice liver (A) and kidney (B) caused by d-gal. Data represent means ± SD (n = 8). ^# p < 0.05 compared with the normal group; * p < 0.05 compared with the model group. Normal: normal control group; Model: d-gal-treated group; VE: d-gal plus VE treatment group; COS-L: d-gal plus COS (300 mg/kg/day) treatment group; COS-M: d-gal plus COS (600 mg/kg) treatment group; COS-H: d-gal plus COS (1200 mg/kg) treatment group.